First Eagle Investment's PROF Position Overview
First Eagle Investment (via First Eagle Investment Management, LLC) currently holds 312,707 shares of Profound Medical Corp. (PROF) worth $2.46 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, First Eagle Investment has maintained this position in PROF for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 169,352 shares.
Analysis based on 13F filings available since 2013 Q2
First Eagle Investment's Profound Medical (PROF) Holding Value Over Time
Track share changes against reported price movement
Quarterly Profound Medical (PROF) Trades by First Eagle Investment
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +21,316 | Add 7.32% | 312,707 | $7.87 |
| Q3 2025 | +169,352 | Add 138.77% | 291,391 | $4.98 |
| Q2 2025 | +122,039 | New Buy | 122,039 | $5.90 |
First Eagle Investment's Profound Medical Investment FAQs
First Eagle Investment first purchased Profound Medical Corp. (PROF) in Q2 2025, acquiring 122,039 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
First Eagle Investment has held Profound Medical Corp. (PROF) for 3 quarters since Q2 2025.
First Eagle Investment's largest addition to Profound Medical Corp. (PROF) was in Q3 2025, adding 291,391 shares worth $1.45 M.
According to the latest 13F filing for Q4 2025, First Eagle Investment's firm, First Eagle Investment Management, LLC, owns 312,707 shares of Profound Medical Corp. (PROF), valued at approximately $2.46 M.
As of the Q4 2025 filing, Profound Medical Corp. (PROF) represents approximately 0.00% of First Eagle Investment's publicly disclosed stock portfolio, making it one of their key holdings.
First Eagle Investment's peak holding in Profound Medical Corp. (PROF) was 312,707 shares, as reported at the end of Q4 2025.